Evaluation of Renal Function Using the Level of Neutrophil Gelatinase-Associated Lipocalin is Not Predictive of Nephrotoxicity Associated with Cisplatin-Based Chemotherapy

Kos, F. Tugba; Sendur, Mehmet Ali Nahit; Aksoy, Sercan; Celik, Huseyin Tugrul; Sezer, Sevilay; Civelek, Burak; Yaman, Sebnem; Zengin, Nurullah

추천

검색

자료유형: 학술저널

저자정보: Kos, F. Tugba (Department of Medical Oncology, Kahramanmaras Sutcu Imam University Faculty of Medicine) Sendur, Mehmet Ali Nahit (Department of Medical Oncology, Ankara Numune Education and Research Hospital) Aksoy, Sercan (Department of Medical Oncology, Hacettepe University Institute of Oncology) Celik, Huseyin Tugrul (Department of Biochemistry, Fatih University Faculty of Medicine) Sezer, Sevilay (Department of Biochemistry, Ankara Numune Education and Research Hospital) Civelek, Burak (Department of Medical Oncology, Ankara Numune Education and Research Hospital) Yaman, Sebnem (Department of Medical Oncology, Ankara Numune Education and Research Hospital) Zengin, Nurullah (Department of Medical Oncology, Ankara Numune Education and Research Hospital)

저널정보: 아시아태평양암예방학회 Asian Pacific journal of cancer prevention : APJCP Asian Pacific journal of cancer prevention : APJCP 제14권 제2호

발행연도: 2013.1

수록면: 1,111 - 1,114 (4page)

이용수

📌

연구주제

📖

연구배경

🔬

연구방법

🏆

연구결과

초록· 키워드

오류제보하기

Background: For early detection of renal damage during the usage of cisplatin based chemotherapy, changes in renal function should be monitored carefully. In recent years, neutrophil gelatinase-associated lipocalin, a small polypeptide molecule, has shown promise as a marker of acute renal failure. The aim of this present study was to assess possible risk prediction of cisplatin-induced nephrotoxicity using serum NGAL. Materials and Methods: A total of 34 consecutive patients with documented serum creatinine at least 24 hours before every cycle of cisplatin-based chemotherapy were included in the study. Demographic and medical data including age, performance status, tumor characteristics and comorbid diseases were collected from medical charts. Renal function was evaluated at least 48 hours before the treatment and at the end of the treatment based on the Modification of Diet in Renal Disease (MDRD) formula. Before and after cisplatin infusion serum NGAL levels were measured for the first and 3rd cycles of chemotherapy. Results: The median age of the study population was 54 (32-70) years. Fifteen patients (41.1%) were treated on an adjuvant basis, whereas 19 patients (58.9%) were treated for metastatic disease. There was no correlation of serum NGAL levels with serum creatinine (r=0.20, p=0.26) and MDRD (r=-0.12, p=0.50) and creatinine clearance-Cockcroft-Gault (r=-0.22, p=0.22) after cisplatin infusion at the end of the 3rd cycle of chemotherapy. Conclusions: In our study, serum NGAL levels were not correlated with the cisplatin induced nephrotoxicity. Further prospective studies are needed to conclude that serum NGAL level is not a good surrogate marker to predict early cisplatin induced nephrotoxicity.

#Chemotherapy #cisplatin #neutrophil gelatinase-associated lipocalin

참고문헌 (0)

참고문헌 신청

참고문헌이 DBpia에서 서비스 중이라면, [참고문헌 신청]을 통해 등록해보세요